February 09, 2021 – Funding
The Lymphoma & Myeloma Program of the Dana Farber/Harvard Cancer Center seeks applications for a Career Enhancement Award in Myeloma Research. Funding has been provided through a grant from the National Cancer Institute...
February 04, 2021 – Announcements
This is a live event moderated by FOX Sports Senior Correspondent Pam Oliver and featuring four-time Olympian and breast cancer survivor Chaunté Lowe; basketball Hall of Famer and humanitarian Dikembe Mutombo; and cancer...
February 02, 2021
The Health Communication Core is working with DF/HCC investigators to pivot recruitment efforts into online channels, submit innovative grant applications, and enhance new models of patient care.
January 27, 2021
The recorded videos for the 8th Annual DF/HCC Celebration of Early Career Investigators in Cancer Research Symposium, which was held virtually on January 21, 2021, are now available.
January 21, 2021 – Announcements
Early career investigators are a unique reservoir of new ideas, innovation, and excellence in cancer research. To celebrate this, we welcome you to join the 8th Annual DF/HCC Celebration of Early Investigators in Cancer...
January 19, 2021 – Announcements
Dr. Kanarek joins DF/HCC as a member of the Leukemia Program.
December 30, 2020 – Funding
The National Cancer Institute (NCI) is providing an opportunity for supplemental funding to support exploratory research studies to expand the current understanding of cancer stigma, assess its impact on cancer control...
December 30, 2020 – Funding
A funding opportunity previously limited to DFCI investigators (the Dana-Farber/Novartis Drug Discovery & Translational Research Program, DDTRP) will soon open to all independent investigators at DF/HCC member...
December 17, 2020 – Event Highlight
The DF/HCC Cancer Data Science Program & Harvard Chan Bioinformatics Core Joint Symposium on scRNAseq Methodology recorded video is now available.
December 08, 2020
NCI has just released a time sensitive Request for Information (RFI) seeking input from all parties who may be interested in the re-competition of the NCI’s Frederick National Laboratory for Cancer Research (FNLCR)....